Myofibroblasts could be recruited in a chemokine (C-C motif) ligand 2-dependent manner in pathogenesis of oral submucous fibrosis

被引:14
作者
Sarode, Gargi [1 ]
Sarode, Sachin C. [1 ]
Deshmukh, Revati [1 ]
Raktade, Prashant [2 ]
Patil, Shankargouda [3 ]
机构
[1] Dr DY Patil Dent Coll & Hosp, Dept Oral Pathol & Microbiol, Pune 18, Maharashtra, India
[2] Pandit Deendayal Upadhay Dent Coll & Hosp, Dept Oral & Maxillofacial Surg, Solapur, Maharashtra, India
[3] Jazan Univ, Coll Dent, Dept Maxillofacial Surg & Diagnost Sci, Div Oral Pathol, Jazan, Saudi Arabia
关键词
CCL2; monocyte chemoattractant protein-1; myofibroblasts; oral submucous fibrosis; alpha-SMA; MONOCYTE CHEMOATTRACTANT PROTEIN-1; SQUAMOUS-CELL CARCINOMA; SYSTEMIC-SCLEROSIS; STROMAL MYOFIBROBLASTS; PULMONARY-FIBROSIS; EXPRESSION; FIBROBLASTS; ETIOLOGY; DISEASE; CCL2;
D O I
10.1111/jop.12543
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
BACKGROUND: Monocyte chemoattractant protein-1 (CCL2) is a major profibrotic mediator with a proven role in fibrosis of different organs of the body. Recently, increased fibrosis in oral submucous fibrosis (OSMF) is linked with betel quid-related chronic irritation and myofibroblast. Hence, this study is designed to investigate expression of CCL2 in OSMF and its correlation with myofibroblasts. MATERIALS AND METHODS: Paraffin-embedded specimens of 30 OSMF and 10 tissues of normal buccal mucosa were subjected to immunohistochemical analysis for CCL2 and alpha-smooth muscle actin (alpha-SMA) expression. RESULTS: CCL2 expression in basal cells (CCL2-B) and connective tissue (CCL2-CT), and a-SMA showed significantly increased expression in advanced OSMF as compared with early OSMF and controls. Significant differences were observed in the expression of CCL2-B between control vs. OSMF (P = 0.002), control vs. advanced OSMF (P = 0.005), and early vs. advanced OSMF (P = 0.0377). Similarly, differences in the CCL2-CT expression were statistically significant between control vs. OSMF (P = 0.00086), control vs. early OSMF (P = 0.02914), and control vs. advanced OSMF (P = 0.0006). For alpha-SMA expression, significant differences were observed between control vs. OSMF (P = 0.0003), control vs. early OSMF (P = 0.036), control vs. advanced OSMF (P = 0.00008), and early vs. advanced OSMF (P = 0.0009). In OSMF group, a significant correlation was observed between CCL2-B and CCL2-CT(P < 0.00001), CCL2-B and alpha 0-SMA(P < 0.00001), and CCL2-CT and alpha-SMA (P < 0.00001). CONCLUSION: CCL2 could be responsible for pathogenesis of OSMF by recruiting myofibroblasts.
引用
收藏
页码:443 / 447
页数:5
相关论文
共 26 条
  • [1] Betel nut chewing and its deleterious effects on oral cavity
    Anand, Richa
    Dhingra, Chandan
    Prasad, Sumanth
    Menon, Ipseeta
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (03) : 499 - 505
  • [2] Evaluation of myofibroblasts in oral submucous fibrosis: correlation with disease severity
    Angadi, Punnya V.
    Kale, Alka D.
    Hallikerimath, Seema
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2011, 40 (03) : 208 - 213
  • [3] MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) EXPRESSION OCCURS IN TOXIC RAT-LIVER INJURY AND HUMAN LIVER-DISEASE
    CZAJA, MJ
    GEERTS, A
    XU, J
    SCHMIEDEBERG, P
    JU, Y
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 55 (01) : 120 - 126
  • [4] Distler O, 2001, ARTHRITIS RHEUM-US, V44, P2665, DOI 10.1002/1529-0131(200111)44:11<2665::AID-ART446>3.0.CO
  • [5] 2-S
  • [6] Galindo M, 2001, ARTHRITIS RHEUM-US, V44, P1382, DOI 10.1002/1529-0131(200106)44:6<1382::AID-ART231>3.0.CO
  • [7] 2-T
  • [8] Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma - An immunohistochemical study
    Gupta, Kanupriya
    Metgud, Rashmi
    Gupta, Jatin
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (04) : 893 - 898
  • [9] Hogaboam GM, 1999, J IMMUNOL, V163, P2193
  • [10] Stromal myofibroblasts in oral squamous cell carcinoma and potentially malignant disorders
    Jayaraj, G.
    Sherlin, H. J.
    Ramani, P.
    Premkumar, P.
    Natesan, A.
    [J]. INDIAN JOURNAL OF CANCER, 2015, 52 (01) : 87 - +